Home » Stocks » SGRY

Surgery Partners, Inc. (SGRY)

Stock Price: $31.04 USD 0.48 (1.57%)
Updated Jan 19, 2021 3:36 PM EST - Market open
Market Cap 1.55B
Revenue (ttm) 1.83B
Net Income (ttm) -179.30M
Shares Out 48.88M
EPS (ttm) -3.69
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $31.04
Previous Close $30.56
Change ($) 0.48
Change (%) 1.57%
Day's Open 30.99
Day's Range 30.32 - 31.94
Day's Volume 175,751
52-Week Range 4.68 - 31.94

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

BRENTWOOD, Tenn., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (the “Company”) will be meeting with investors as part of the 2021 J.P. Morgan Healthcare Co...

GlobeNewsWire - 3 weeks ago

BRENTWOOD, Tenn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today...

Seeking Alpha - 3 weeks ago

Surgery Partners runs surgical hospitals and ambulatory surgery centres in partnership with physicians, handling the non-specialist side of the business. The company's share price hit a low of...

Zacks Investment Research - 3 weeks ago

Bear of the Day: Surgery Partners (SGRY)

Zacks Investment Research - 1 month ago

Investors need to pay close attention to Surgery Partners (SGRY) stock based on the movements in the options market lately.

GlobeNewsWire - 2 months ago

BRENTWOOD, Tenn., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today...

Seeking Alpha - 2 months ago

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Surgery Partners (SGRY) delivered earnings and revenue surprises of -76.67% and 10.57%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the...

Benzinga - 2 months ago

  Shares of Surgery Partners (NASDAQ:SGRY) decreased 0.3% in pre-market trading after the company reported Q3 results.

Zacks Investment Research - 2 months ago

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 2 months ago

BRENTWOOD, Tenn., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, annou...

PRNewsWire - 4 months ago

IRVING, Texas, Sept. 15, 2020 /PRNewswire/ -- NorthStar Anesthesia ("NorthStar" or the "Company"), one of the country's leading anesthesia care providers and managers, today announced that Ane...

Seeking Alpha - 5 months ago

Surgery Partners, Inc.'s (SGRY) CEO Eric Evans on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Surgery Partners (SGRY) delivered earnings and revenue surprises of 5.88% and 1.22%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

BRENTWOOD, Tenn., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, tod...

Zacks Investment Research - 5 months ago

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 5 months ago

BRENTWOOD, Tenn., July 24, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Cente...

GlobeNewsWire - 5 months ago

BRENTWOOD, Tenn., July 21, 2020 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, ann...

Seeking Alpha - 8 months ago

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Surgery Partners (SGRY) delivered earnings and revenue surprises of 41.38% and 16.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Seeking Alpha - 10 months ago

Surgery Partners, Inc. (SGRY) CEO Eric Evans on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Surgery Partners (SGRY) delivered earnings and revenue surprises of -16.67% and 2.60%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the s...

Zacks Investment Research - 10 months ago

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 11 months ago

Does Surgery Partners (SGRY) have what it takes to be a top stock pick for momentum investors? Let's find out.

GlobeNewsWire - 1 year ago

Wayne S. DeVeydt appointed to Executive Chairman of the Board Eric Evans appointed to Chief Executive Officer Company reaffirms 2019 full year guidance of double-digit Adjusted EBITDA growth

Zacks Investment Research - 1 year ago

Zendesk (ZEN), Surgery Partners (SGRY) and Tesla (TSLA) Are Aggressive Growth Stocks

A look a three names on your aggressive growth stock radar screen.

Other stocks mentioned: TSLA, ZEN
Zacks Investment Research - 1 year ago

Surgery Partners is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Zacks Investment Research - 1 year ago

As of late, it has definitely been a great time to be an investor in Surgery Partners.

Seeking Alpha - 1 year ago

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q3 2019 Results - Earnings Call Transcript

GuruFocus - 1 year ago

EVP & COO of Surgery Partners Inc (30-Year Financial, Insider Trades) Jason Eric Evans (insider trades) bought 25,000 shares of SGRY on 08/20/2019 at an average price of $5.95 a share.

Seeking Alpha - 1 year ago

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Surgery Partners (SGRY) delivered earnings and revenue surprises of -70.59% and -0.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Surgery Partners, Inc. (SGRY) CEO Wayne DeVeydt on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

About SGRY

Surgery Partners, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancil... [Read more...]

Industry
Medical Care Facilities
IPO Date
Oct 1, 2015
CEO
J. Eric Evans
Employees
6,900
Stock Exchange
NASDAQ
Ticker Symbol
SGRY
Full Company Profile

Financial Performance

In 2019, SGRY's revenue was $1.83 billion, an increase of 3.38% compared to the previous year's $1.77 billion. Losses were -$74.80 million, -63.64% less than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for SGRY stock is "Buy." The 12-month stock price forecast is 31.33, which is an increase of 0.93% from the latest price.

Price Target
$31.33
(0.93% upside)
Analyst Consensus: Buy